Drug Designing and Biomarkers

Drug designing is an inventive process of finding new medication based on the target knowledge. A drug is commonly a small compound which produces a therapeutic effect. There are different methods of drug designing. Designing a drug based on the three-dimensional structure and computational techniques are known as structure-based drug design and computer aided drug design respectively. There are various stages involved in computer aided drug design such as hit identification, hit to lead optimization and lead optimization. In structure-based drug design, the structure is obtained either through x-ray crystallography or NMR spectroscopy. Ligand-based drug design depends on the knowledge of molecules that bind to the biological target of our interest. Correlation between calculated and theoretical can be derived and this QSAR relationship is used to derive analogues.

Biomarkers include tools and technologies that aid in dynamic and powerful approach to understand the spectrum of neurological diseases in knowing the prediction, cause, diagnosis, progression, regression, or outcome of treatment of a disease.

 

  • Drug targets
  • Ligand-based design
  • Structure-based design
  • Scoring functions
  • Adrenergic receptor
  • Protein crystallography

Related Conference of Drug Designing and Biomarkers

December 14-14, 2020

2nd Pathology and Infectious Disease Conference

Dubai, UAE
March 28-29, 2021

11th Glycobiology World Congress

Vienna, Austria
April 24-24, 2021

2nd International Conference on Nucleic Acids

London, UK
June 11-12, 2021

25th Global Congress on Biotechnology

Berlin, Germany
September 13-14, 2021

17th World Congress on Structural Biology

Prague, Czech Republic
September 27-28, 2021

25th European Biotechnology Congress

Dublin, Ireland

Drug Designing and Biomarkers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in